Jan 8, 2026In contrast to diabetic ketoacidosis,insulintherapyis not necessary for managing ketoacidosis associated with GLP-1-basedtherapy; however,insulintherapymay be indicated if concomitant diabetic ketoacidosis orinsulindeficiency is suspected.
This article looks at howGLP-1affectsinsulinresistance. It shares new findings and the latest in research andtreatment. We want to show howGLP-1can improveinsulinuse and change diabetes care. The Role ofGLP-1inInsulinResistanceGLP-1andinsulinresistanceare closely linked. It's key to understand whatinsulinresistanceis first. Then, we can see howGLP-1helps makeinsulin...
Glucagon-like peptide-1 (GLP-1) agonists have emerged as a groundbreaking class of medications for managing type 2 diabetes and associated metabolic disorders. These agents not only improve glycemic control by increasinginsulinsecretion and ...
Nov 18, 2025Before people realized that " Ozempic cures all diseases,"GLP-1receptor agonists were originally developed solely as atreatmentforinsulinresistance/Type 2 diabetes. Decades ago, when the first generation ofGLP-1receptor agonists were being developed to treat T2D, researchers thought they would primarily work by stimulatinginsulinproduction. The body responds to earlyinsulin...
Aug 1, 2024AlthoughGLP-1receptor agonists improveinsulinsensitivity secondary to weight loss, the only true directinsulin-sensitising drugs are thiazolidinediones. Because of side-effects associated with type 2 diabetestherapy, these drugs have not gained widespread use.
Apr 25, 2025Glucagon-like peptide1(GLP-1)-based therapies, such as semaglutide and tirzepatide, represent highly effectivetreatmentoptions for people with type 2 diabetes and obesity, enabling effective ...
Sep 1, 2024GLP-1, an incretin hormone, plays a crucial role in glucose metabolism and appetite regulation, influencinginsulinsecretion,insulinsensitivity, and gastric emptying. The therapeutic use ofGLP-1RAs has evolved significantly, offering various formulations that provide different efficacy, routes of administration, and flexibility in dosing.
The combination of basalinsulinand aGLP-1receptor agonist offers several potential benefits to patients with type 2 diabetes. This review focuses on the rationalefor, clinical evidence on, and implications of the combination of basalinsulinandGLP-1receptor agonists in thetreatmentof type 2 diabetes.
Jan 21, 2025It discusses the evidence supporting the use of glucagon-like peptide-1 receptor agonists (GLP-1RA) as potential adjunctivetherapyin T1D to reduce weight and improveinsulinresistance. Potential benefits need to be weighed against the risk of hypoglycemia and lack of long-term data.
By early 2025, nearly 25% of diabetes patients had started aGLP‑1therapy, up from just 3% four years ago. This rapid growth is driven byGLP-1'sproven ability to lower blood sugar and support meaningful weight loss, makingGLP-1sa game-changer for both patients and providers. The impact ofGLP‑1sextends well beyond diabetes and obesity.
7 days agoAreGLP-1agonists psychiatric drugs? The neuroscience of reward, new addiction trial data, and a dosing hypothesis that reframes anhedonia.
Key TakeawaysGLP-1medications can improve fertility in women with PCOS through weight loss andinsulinsensitivity Most manufacturers recommend discontinuingGLP-1drugs before planned pregnancy due to limited safety data Weight loss fromGLP-1therapymay restore ovulation in women with obesity-related fertility issues Current research shows promising but limited data onGLP-1fertility ...
2 days agoYour body's metabolism, like body fat andinsulinresistance, greatly affects how wellGLP-1works. Sticking to yourtreatmentplan and making lasting lifestyle changes are also key for good results.
Mar 16, 2026ExploreGLP-1blood pressure effects and how these diabetes therapies improve vascular health, reduce hypertension, and support cardiometabolic outcomes.
Apr 14, 2025Learn howGLP-1drugs work for diabetes and weight loss. ExploreGLP-1benefits, side effects, and emerging research on these medications.
5 days agoHowever, responsible clinicians have consistently and strongly encouraged endurance exercise,resistancetraining, and walking or jogging for every patient onGLP-1RAtherapy.
Together, these strategies create a comprehensive approach to managinginsulinresistanceand enhancing overall health. Ultimately, empowering women to take charge of their health through informed choices and community support can lead to significant improvements ininsulinsensitivity and weight loss.
Insulintherapyoften is an important part of diabetestreatment. It helps keep blood sugar under control and prevents diabetes complications. It works like the hormoneinsulinthat the body usually makes.
Researchers therefore developedGLP-1receptor agonists, drugs that mimic the effects ofGLP-1but remain active for longer periods. The firstGLP-1receptor agonist was approved in 2005 for thetreatmentof type 2 diabetes, marking a major milestone in metabolic medicine.
/assets/production/practices/8b0d3bb90a4a057da79711c047bb7841fe69b974/images/2795992.jpg "Tirzepatide GLP1 Microdosing for Weight Loss Explained")
TodayLearn how tirzepatideGLP1microdosing works for weight loss, the benefits of low-dosetherapy, and safe options for women with hormonal weight gain.
Dr. McLaughlin breaks down who may qualify forGLP-1therapy👇 You may be a candidate if you have: ️ BMI ≥30 (obesity), or ️ BMI ≥27 with at least one weight-related condition (type 2 diabetes, hypertension, dyslipidemia, sleep apnea) ️ Type 2 diabetes or prediabetes ️Insulinresistanceor metabolic syndrome ️ Cardiovascular ...
TodayGLP-1therapies have expanded beyond diabetes and obesitytreatment, displaying vascular and potential mental health benefits. Rare risks highlight the need for personalized care and continued pharmacovigilance as their use grows.
4 days agoGLP-1medications are used to address weight gain and metabolic changes during perimenopause and menopause, targeting appetite regulation,insulinresistance, and energy balance. BrandedGLP-1s, such as Wegovy® and Ozempic®, are FDA-approved, standardized, and supported by extensive clinical data, while compoundedGLP-1sare custom-prepared by licensed pharmacies for cases of drug shortages ...
Key TakeawaysGLP-1medications can restore ovulation in women with PCOS by improvinginsulinsensitivity Weight loss fromGLP-1therapymay normalize hormone levels that boost fertility Multiple studies show increased pregnancy rates in women usingGLP-1agonists Discontinuation before conception is recommended due to limited pregnancy safety data The term "Ozempic babies" has gained ...
5 days agoMonitor for nutritional deficiencies, particularly vitamin D (occurring in 7.5-13.6% of users), iron depletion, and inadequate calcium and protein intake 4 Cardiometabolic Benefits Beyond weight loss,GLP-1receptor agonists improve: Fastinginsulinlevels 3Insulinresistancemarkers 3 β-cell function 3 Cardiometabolic risk profile1
1 day agoStepTherapyand Alternatives Steptherapymeans starting with lower-cost options before "stepping up" to more expensive drugs. For diabetes, Ambetter often requires metformin first, followed by a DPP-4 inhibitor, sulfonylurea, or SGLT2 inhibitor before approving aGLP-1like Mounjaro. If steptherapyis not met, the PA will be denied.
Sep 18, 2024In recent years,GLP-1medications have become a focal point in the medical community due to their innovativetreatmentmechanisms, significant therapeutic efficacy, and broad development prospects.
7 days agoAllulose (D-psicose) is a rare monosaccharide sugar naturally occurring at low concentrations in select foods including figs, raisins, wheat, maple syrup, and molasses.
Today• A women-focused approach toGLP-1therapythat goes beyond generic advice • Clear explanations of howGLP-1medications work and why they matter • Dedicated chapters on PCOS, perimenopause, menopause, cortisol, stress,insulinresistance, and metabolic change • Practical guidance for starting your journey and understanding what to expect